Clostridium difficile Infection and Fecal Microbiota Transplant

Alyssa Liubakka1, Byron P Vaughn1

  • 1Alyssa Liubakka is an Internal Medicine Resident, Department of Medicine, University of Minnesota, 420 Delaware Street SE, MMC 284, Minneapolis, MN 55455 (e-mail: liuba006@umn.edu). Byron P. Vaughn is an Assistant Professor of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, and part of the Microbiota Therapeutics Program, University of Minnesota, Minneapolis, Minnesota.

AACN Advanced Critical Care
|December 14, 2016
PubMed

Insights

Clostridium difficile infection (CDI) is a significant healthcare concern. Fecal microbiota transplant (FMT) shows high efficacy for recurrent CDI, offering a novel treatment option.

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Microbiology

Background:

  • Clostridium difficile infection (CDI) causes significant morbidity and mortality in hospitalized patients.
  • Up to 30% of patients experience recurrent CDI despite existing antimicrobial therapies.

Purpose of the Study:

  • To review the epidemiology, diagnosis, and treatment of CDI.
  • To evaluate the role of fecal microbiota transplant (FMT) for recurrent, severe, or refractory CDI.

Main Methods:

  • Literature review of CDI epidemiology, diagnosis, and treatment modalities.
  • Analysis of studies on fecal microbiota transplant efficacy for recurrent CDI.

Main Results:

  • Fecal microbiota transplant demonstrates nearly 90% efficacy in patients with multiple recurrent CDI.
  • FMT is a promising approach for severe or refractory CDI cases.

Conclusions:

  • Fecal microbiota transplant is a highly effective treatment for recurrent Clostridium difficile infection.
  • FMT represents a significant advancement in managing complex CDI cases.

Related Concept Videos

What is Monogastric Digestion?01:50

What is Monogastric Digestion?

The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
76.8K
Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
1.8K
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.1K
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
791